Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$576K Buy
4,791
+555
+13% +$64.1K 0.12% 108
2025
Q4
$446K Buy
4,236
+247
+6% +$23.2K 0.09% 131
2025
Q3
$335K Buy
3,989
+6
+0.2% +$494 0.07% 154
2025
Q2
$313K Sell
3,983
-31,083
-89% -$2.47M 0.07% 153
2025
Q1
$3.15M Sell
35,066
-558
-2% -$52.1K 0.82% 33
2024
Q4
$3.54M Sell
35,624
-523
-1% -$53.9K 0.93% 24
2024
Q3
$4.1M Sell
36,147
-1,225
-3% -$146K 1.09% 25
2024
Q2
$4.63M Buy
37,372
+1,106
+3% +$142K 1.33% 23
2024
Q1
$4.79M Buy
36,266
+1,893
+6% +$233K 1.4% 20
2023
Q4
$3.75M Buy
+34,373
New +$3.57M 1.25% 24

Other funds holding MRK

Stonebrook Private's MRK Position: Q1 2026 in Review

Stonebrook Private increased its Merck (MRK) stake by 13% in Q1 2026, buying an estimated $64.1K and bringing the position to 4,791 shares worth $576K. The position accounts for 0.12% of the portfolio, ranked #108.

Stonebrook Private first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.79M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Stonebrook Private held 4,791 shares of Merck worth $576K as of Q1 2026.
  • Stonebrook Private bought 555 Merck shares in Q1 2026, an estimated $64.1K.
  • Merck made up 0.12% of Stonebrook Private's portfolio in Q1 2026, its #108 holding.
  • Stonebrook Private first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Stonebrook Private's Merck position peaked at $4.79M in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Stonebrook Private's 13F filing for Q1 2026, filed 11 May 2026.